Jesse Jackson’s misdiagnosis of Parkinson’s is common – new genetic discovery could lead to treatment for this deadly disease

People typically die from progressive supranuclear palsy within 7 to 10 years. There is currently no specialized treatment or effective screening for this neurodegenerative disease.
The Lancet

Ten unanswered questions about dipeptidyl peptidase-1 inhibition in bronchiectasis

The dipeptidyl peptidase-1 (DPP1) inhibitor brensocatib became the first licensed therapy for bronchiectasis in the USA and Europe in 2025,1 based on the phase 3 ASPEN trial showing an approximate 20% ...

‘Betrayed’: Families are dealing with dashed hopes after pivot on autism treatment

The drug leucovorin was touted by the Trump administration in September as a potential treatment for thousands of children with autism. Now, some parents and guardians of children with autism say they ...
Infectious Disease Advisor

Gepotidacin May Be Alternative Option for Early Uncomplicated UTI Treatment

Gepotidacin and nitrofurantoin demonstrate similar efficacy in reducing symptom severity and restoring daily function in women with uncomplicated UTI.
Medscape

Will New Polymyalgia Rheumatica Treatments Lessen Need for ‘Improvisation’?

As IL-6 inhibition comes into practice for PMR, research advances on other therapeutic mechanisms of action, from IL-17 to ...